Thoroughbred Financial Services, LLC Amgen Inc Transaction History

Thoroughbred Financial Services, LLC

$1.04 Billion
Q1 2024

A detailed history of Thoroughbred Financial Services, LLC transactions in Amgen Inc stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 8,665 shares of AMGN stock, worth $2.69 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

8,665

Previous 14,178 38.88%

Holding current value

$2.69 Million

Previous $4.08 Million 39.68%

% of portfolio

0.24%

Previous 0.33%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $1.48 Million - $1.79 Million	-5,513 Reduced 38.88%	8,665 $2.46 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $252,631 - $284,998	988 Added 7.49%	14,178 $4.08 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $970,150 - $1.2 Million	4,437 Added 50.69%	13,190 $3.55 Million
Q2 2023 Aug 03, 2023	SELL	$214.27 - $253.37 $11,570 - $13,681	-54 Reduced 0.61%	8,753 $1.94 Million
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $54,641 - $66,598	-242 Reduced 2.67%	8,807 $2.13 Million

Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $52,218 - $66,350	228 Added 2.58%	9,049 $2.38 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $17,732 - $19,998	79 Added 0.9%	8,821 $1.99 Million
Q2 2022 Aug 03, 2022	BUY	$230.71 - $256.74 $77,287 - $86,007	335 Added 3.98%	8,742 $2.13 Million
Q1 2022 May 04, 2022	BUY	$219.27 - $242.57 $1.06 Million - $1.18 Million	4,857 Added 136.82%	8,407 $2.03 Million
Q4 2021 Feb 09, 2022	SELL	$198.88 - $227.6 $118,930 - $136,104	-598 Reduced 14.42%	3,550 $798,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $48,822 - $57,201	-230 Reduced 5.25%	4,148 $882,000
Q2 2021 Jul 27, 2021	SELL	$233.58 - $259.14 $125,198 - $138,899	-536 Reduced 10.91%	4,378 $1.07 Million
Q1 2021 Apr 30, 2021	SELL	$221.91 - $258.6 $30,623 - $35,686	-138 Reduced 2.73%	4,914 $1.22 Million
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $16,228 - $19,325	-75 Reduced 1.46%	5,052 $1.16 Million
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $27,923 - $31,053	-119 Reduced 2.27%	5,127 $1.3 Million
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $1.04 Million - $1.28 Million	-5,277 Reduced 50.15%	5,246 $1.24 Million
Q1 2020 Apr 23, 2020	SELL	$182.24 - $241.7 $36,630 - $48,581	-201 Reduced 1.87%	10,523 $2.13 Million
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $50,708 - $65,177	268 Added 2.56%	10,724 $2.59 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $114,738 - $137,480	659 Added 6.73%	10,456 $2.02 Million
Q2 2019 Jul 16, 2019	SELL	$166.7 - $195.41 $299 Million - $351 Million	-1,795,595 Reduced 99.46%	9,797 $0
Q2 2019 Jul 16, 2019	BUY	$166.7 - $195.41 $299 Million - $351 Million	1,796,156 Added 19447.34%	1,805,392 $0
Q1 2019 May 07, 2019	SELL	$180.87 - $203.88 $6,149 - $6,931	-34 Reduced 0.37%	9,236 $1.76 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $1.65 Million - $1.93 Million	9,270 New	9,270 $1.8 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.

Account

Thoroughbred Financial Services, LLC Amgen Inc Transaction History